⌘K

Login Start Free

Home/Filings/4/0000905718-22-000042

4//SEC Filing

Mento Steven J 4

Accession 0000905718-22-000042

CIK 0001853816other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 7:03 PM ET

Size

5.2 KB

Accession

0000905718-22-000042

Insider Transaction Report

Form 4

Period: 2022-01-03

Dermata Therapeutics, Inc.DRMA

Director

Transactions

Award
Stock Option (right to Buy)
2022-01-03+5,000→ 5,000 total
Exercise: $1.88Exp: 2032-01-02→ Common Stock (5,000 underlying)

Footnotes (1)

[F1]The option vests in twelve equal monthly installments commencing January 3, 2022.

Documents

1 file

4
dermata_fm4jan32022.xmlPrimary

Issuer

Dermata Therapeutics, Inc.

CIK 0001853816

Entity typeother

Related Parties

1

filerCIK 0001324466

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 7:03 PM ET
Size: 5.2 KB

View on SEC.gov